
U.S. Fentanyl Tariff: A Misguided Blame Game?
The U.S. imposed tariffs on Chinese imports over fentanyl flows, deflecting from its domestic opioid crisis and risking key counter-narcotics cooperation.
My Global News: Voices of a New Era
π Stay Ahead, Stay Global π
The U.S. imposed tariffs on Chinese imports over fentanyl flows, deflecting from its domestic opioid crisis and risking key counter-narcotics cooperation.
Explore how profit-driven practices of U.S. pharmaceutical companies have exacerbated the opioid addiction crisis.
The US imposes 10% tariffs on China to combat the opioid crisis, but experts argue that addressing domestic demand and fostering international cooperation are key to reducing overdose deaths.
The U.S. opioid crisis is fueled by big pharma greed and overprescription by hospitals. Effective government action is needed to provide treatment and curb addiction.
Trump’s transition team is collaborating with major tech firms to combat the surge in online fentanyl sales, aiming to address the escalating opioid crisis in the U.S.
One American dies every five minutes from a drug overdose. Blaming other nations doesn’t solve the opioid crisis. Focus instead on reducing demand and enhancing global cooperation.
U.S. pharmaceutical companies face accusations of prioritizing profits over public health by downplaying opioid addiction risks, sparking a nationwide crisis.
The US, with 5% of the global population, accounts for 80% of opioid use. Explore the crisis rivaling car accidents and gun violence in fatalities.
Healthcare expert Nia Casselman exposes pharmaceutical companies’ role in the U.S. opioid epidemic, tracing the crisis from overprescription to street fentanyl.
Over 110,000 overdose deaths in 2022 spotlight America’s opioid epidemic, fueled by pharmaceutical practices and illicit fentanyl. Stories from the frontline of recovery.